Airway Inflammation and Host Responses in the Era of CFTR Modulators

Airway Inflammation and Host Responses in the Era of CFTR Modulators

The arrival of cystic fibrosis transmembrane conductance regulator (CFTR) modulators as a new class of treatment for cystic fibrosis (CF) in 2012 represented a pivotal advance in disease management, as these small molecules directly target the upstream underlying protein defect. Further advancements...

Full description

Bibliographic Details
Main Authors: Karen Keown, Ryan Brown, Declan F. Doherty, Claire Houston, Michael C. McKelvey, Shannice Creane, Dermot Linden, Daniel F. McAuley, Joseph C. Kidney, Sinéad Weldon, Damian G. Downey, Clifford C. Taggart
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:International Journal of Molecular Sciences
Subjects:
cystic fibrosis
inflammation
infection
CFTR modulator
Online Access:https://www.mdpi.com/1422-0067/21/17/6379

Internet

https://www.mdpi.com/1422-0067/21/17/6379

Similar Items